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The Schiﬀ bases HL1−3 have been prepared by the reaction of 5-bromothiophene-2-carboxaldehyde with 4-amino-5-mercapto-3-
methyl/propyl/isopropyl-s-triazole, respectively. Organosilicon(IV) and organotin(IV) complexes of formulae (CH3)2MCl(L1−3),
(CH3)2M(L1−3)2 were synthesized fromthe reaction of (CH3)2MCl2 and the Schiﬀ bases in 1:1 and 1:2 molar ratio, where M = Si
and Sn. The synthesized Schiﬀ bases and their metal complexes have been characterized with the aid of various physicochemical
techniques like elemental analyses, molar conductance, UV, IR, 1H, 13C, 29Si, and 119Sn NMR spectroscopy. Based on these
studies, the trigonal bipyramidal and octahedral geometries have been proposed for these complexes. The ligands and their metal
complexes have been screened in vitro against some bacteria and fungi.
1.Introduction
Recently, the research relating with metal complexes of
heteronuclear Schiﬀ bases has expanded enormously and
now comprising their interesting aspects in coordination
chemistry with a special emphasis in bioinorganic chemistry.
Auseoforganosiliconandorganotincompoundsasreagents
or intermediates in the inorganic synthesis has further
strengthened their applications [1, 2].
More-over, metal complexes of organosilicon(IV) and
organotin(IV) halides with N, O, and S donor ligands have
received much more consideration due to their industrial,
environmental, and biological applications [3–5]. The N,
O and S donor ligands have been used to enhance the
biological activity of organosilicon and organotin derivatives
[6]. Organosilicon(IV) complexes have been subjected of
interest for their versatile applications in pharmaceutical
and chemical industries. Organosilicon compounds of nitro-
gen and sulphur containing ligands are well known for
their anticarcinogenic, antibacterial, antifungal, tuberculo-
static, insecticidal, and acaricidal activities [7–10]. Generally,
organosilicon complexes seem to owe their antitumor prop-
erties to the immune-defensive system of the organism [11].
Similarly, organotin compounds are the active components
in a number of biocidal formulations in such diverse areas as
fungicides, miticides, molluscicides, antifouling paints and
surface disinfectants [12, 13]. In addition, many organotin
compounds have been tested for a large variety of tumor
lines and found to be more eﬀective than traditional heavy
metal anticancer drugs [14, 15]. Ahmad et al. have also
screened some organotin compounds against tumor cells
[16]. Prompted by these applications, few new organosilicon
and organotin compounds have already been synthesized
and screened for antibacterial and antifungal activities [17,
18], and in continuation to this, in the present paper, the
synthesis, characterization, and biological activities of new
triazole Schiﬀ bases and their organosilicon and organotin
complexes have been carried out.
2. Experimental
Dried solvents were used for the synthesis of compounds.
Reagents,5-bromothiophene-2-carboxaldehyde (Spectro-
chem), Dimethylsilicon-dichloride (Acros) and Dimethyl-
tindichloride (TCI-America) were used as such.
2.1. Analytical Methods and Physical Measurements. Silicon
and tin were determined gravimetrically as silicondioxide2 Bioinorganic Chemistry and Applications
(SiO2) and tindioxide (SnO2). Melting points were deter-
minedonacapillarymeltingpointapparatus.Molarconduc-
tance measurements of 10−3 Ms o l u t i o no fm e t a lc o m p l e x e s
in dry DMF were measured at room temperature (25±1◦C)
with a conductivity bridge type 305 Systronic model. Car-
bon, hydrogen, nitrogen and sulfur were estimated using
elemental analyzer Heraeus Vario EL-III Carlo Erba 1108 at
CDRI Lucknow. The electronic spectra of the ligands and
their metal complexes were recorded in dry methanol, on
a Systronics, Double-beam spectrophotometer 2203, in the
rangeof600–200nm.TheIRspectraoftheligandsandmetal
complexes were recorded in nujol mulls/KBr pellets using
BUCK scientiﬁc M5000 grating spectrophotometer in the
range of 4000–350cm−1. Nuclear magnetic resonance spec-
tra (1H, 13C) were recorded on BRUKER-300ACF and 29Si
and 119Sn were recorded on BRUKER-400ACF spectrometer
in DMSO-d6 using tetramethylsilane (TMS) as an internal
standard.
2.2. Synthesis of Ligands. 4-Amino-5-mercapto-3-methyl-s-
triazole (AMMT), 4-amino-5-mercapto-3-propyl-s-triazole
(AMPT) and 4-amino-3-isoproyl-5-mercapto-s-triazole (AI
MT) were synthesized by reported methods [19, 20]. The
ligands were synthesized by condensation of 5-bromothi-
ophene-2-carboxaldehyde with AMMT, AMPT and AIMT
in the medium of ethanol (Figure 1) .T h ec o n t e n t sw e r e
reﬂuxed for 4–5h in absolute ethanol. After reﬂuxing, the
reaction mixture was kept overnight at room temperature
and the product was ﬁltered, washed, and recrystallized from
same solvent. The elemental analyses and physical properties
of the ligands are reported in Table 1. The three ligands
are: HL1 =4-(5-Bromothiophen-2-carboxylidene amino)-3-
methyl-5-mercapto-s-triazole (BTMMT), HL2 =4-(5-Bro-
mothiophen-2-carboxylideneamino)-5-mercapto-3-propyl-
s-triazole(BTMPT),HL3 =4-(5-Bromothiophen-2-carboxy-
lidene amino)-3-isopropyl-5-mercapto-s-triazole (BTIMT).
2.3. Synthesis of Metal Complexes. To a weighed amount
of dimethylsilicondichloride (Me2SiCl2) and dimethyltin-
dichloride (Me2SnCl2)i n∼30mL of dry methanol, was
added the calculated amount of the sodium salt of the
ligands in 1:1 and 1:2 molar ratios. The sodium salts
of the ligands were prepared by dissolving the appropriate
amount of the sodium metal and ligands in ∼30mL dry
methanol. The reaction mixture was reﬂuxed for about
12h and then allowed to cool at room temperature and
removed the chlorine as sodium chloride. The excess of
solvent was removed under reduced pressure by vacuum
pump and the resulting solid was repeatedly washed with 5–
10mL dry cyclohexane and again dried under vacuum. The
elemental analyses and physical properties of the complexes
are reported in Table 1.
3. Results andDiscussion
The reactions of Me2SiCl2 and Me2SnCl2 with the sodium
salt of monobasic bidentate ligands in 1:1 and 1:2 molar
N
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Figure 1: Structure of Schiﬀ bases, where R=–CH3,H L 1 =4-(5-
Bromothiophen-2-carboxylidene amino)-3-methyl-5-mercapto-s-
triazole (BTMMT); R=–CH2–CH2–CH3,H L 2 =4-(5-Bromo-
thiophen-2-carboxylidene amino)-5-mercapto-3-propyl-s-triazole
(BTMPT); R=–CH(CH3)2,H L 3 =4-(5-Bromothiophen-2-carbox-
ylidene amino)-3-isopropyl-5-mercapto-s-triazole (BTIMT).
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Figure 2: 1H NMR spectrum of Schiﬀ base (HL3).
ratios in methanol medium result in the precipitation of
sodium chloride (NaCl), as shown by following reactions:
Me2MCl2 +N SN a
1:1
− −−−−→ Me2MCl NS+ NaCl
Me2MCl2 +2N SN a
1:2
− −−−−→ Me2M NS
2
+2N aC l,
(1)
where M=Si or Sn and N S represent the donor sites of the
ligands.
T h er e s u l t i n gc o m p l e x e sh a v eb e e no b t a i n e da sc o l o u r e d
solids which are soluble in DMSO, DMF, and MeOH. The
ligands show a sharp melting point, but the complexes
decompose in a range of temperature (200–300◦C). The
molar conductivity values measured for 10−3 M solutions in
anhydrous DMF are in the range of 10–16Ω−1cm2 mol−1,Bioinorganic Chemistry and Applications 3
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Table 2: IR-spectroscopic data (cm−1) of the ligands and their metal complexes.
Compound ν(N–H) ν(–C=N) ν(C=S)a/ν(C–S)b ν(S–H) ν(M–S) ν(M–N) ν(M–Cl)
HL1(BTMMT) 3117 1597 1173 2754 — — —
Me2SiCl(L1) — 1628 717 — 453 572 418
Me2Si(L1)2 — 1628 710 — 458 576 —
Me2SnCl(L1) — 1643 741 — 403 528 378
Me2Sn(L1)2 — 1643 741 — 416 538 —
HL2(BTMPT) 3109 1589 1111 2754 — — —
Me2SiCl(L2) — 1636 702 — 452 570 420
Me2Si(L2)2 — 1697 741 — 446 582 —
Me2SnCl(L2) — 1674 741 — 416 542 396
Me2Sn(L2)2 — 1674 733 — 418 543 —
HL3(BTIMT) 3094 1582 1126 2777 — — —
Me2SiCl(L3) — 1655 756 — 456 563 426
Me2Si(L3)2 — 1659 741 — 452 578 —
Me2SnCl(L3) — 1651 764 — 410 536 395
Me2Sn(L3)2 — 1659 733 — 416 544 —
a=Ligands.
b=Complexes.
Table 3: 1HNMR chemical shifts of the ligands and their metal complexes.
Compound –CH=N –SH Aromatic-H Triazole-CH3,– C H 2–CH2–CH3, –CH(CH3)
HL1(BTMMT) 11.70(s) 10.47 (s) 7.30 (d, 1H, J =3.6Hz);
7.13 (d, 1H, J =3.6Hz) 2.45 (s, 3H)
Me2SiCl(L1)9 . 6 4 ( s ) — 7.35 (d, 1H, J =3.9Hz);
7.14 (d, 1H, J =3.9Hz) 2.42 (s, 3H)
Me2Si(L1)2 11.12(s) — 7.42 (d, 2H, J =3.9Hz);
7.31 (d, 2H, J =3.9Hz) 2.19 (s, 6H)
Me2SnCl(L1) 11.19(s) — 7.26 (d,1H, J =3.0Hz);
7.14 (d, 1H, J =3.0Hz) 2.22 (s, 3H)
Me2Sn(L1)2 11.15(s) — 7.36 (d, 2H, J =3.0Hz);
7.29 (d, 2H, J =3.0Hz) 2.10 (s, 6H)
HL2(BTMPT) 10.91(s) 13.75 (s) 7.31 (d, 1H, J =3.6Hz);
7.13 (d, 1H, J =3.6Hz)
2.78 (t, 2H, J =7.5Hz); 1.69–1.63 (m, 2H); 1.03 (t, 3H,
J =7.5Hz)
Me2SiCl(L2) 10.41(s) — 7.44 (d, 1H, J =3.9Hz);
7.19 (d, 1H, J =3.9Hz)
2.64 (t, 2H, J =7.5Hz); 1.79–1.61(m, 2H); 0.94 (t, 3H,
J =7.5Hz)
Me2Si(L2)2 8.41(s) — 7.43 (d, 2H, J =3.9 Hz);
7.21 (d, 2H, J =3.9Hz)
2.63 (t, 4H, J =7.5Hz); 1.65–1.48 (m, 4H); 0.96 (t, 6H,
J =7.5Hz)
Me2SnCl(L2)8 . 4 9 ( s ) — 7.20 (d, 1H, J =3.9 Hz);
6.88 (d, 1H, J =3.9Hz)
2.62 (t, 2H, J =7.5Hz); 1.79–1.56 (m, 2H); 0.94 (t, 3H,
J =7.5Hz)
Me2Sn(L2)2 8.87(s) — 7.36 (d, 2H, J =3.6Hz);
7.35 (d, 2H, J =3.6Hz)
2.68 (t, 4H, J =7.2Hz); 1.99–1.97 (m, 4H); 1.25 (t, 6H,
J =7.2Hz)
HL3(BTIMT) 10.63(s) 11.10 (s) 7.31(d, 1H, J =3.9Hz);
7.13 (d, 1H, J =3.9Hz) 3.29–3.20 (m, 1H); 1.36 (d, 6H, J =6.9Hz)
Me2SiCl(L3) 10.32(s) — 7.51 (d, 1H, J =3.6Hz);
7.23 (d, 1H, J =3.6Hz) 3.28–3.12 (m, 1H,); 1.25 (d, 6H, J =7.2Hz)
Me2Si(L3)2 8.44(s) — 7.10 (d, 2H, J =3.9Hz);
7.02 (d, 2H, J =3.9Hz) 3.14–2.86 (m, 2H); 1.25 (d,12H, J =7.2Hz)
Me2SnCl(L3)8 . 4 0 ( s ) — 7.12 (d, 1H, J =3.9Hz);
7.08 (d, 1H, J =3.9Hz) 2.87–2.73 (m, 1H); 1.17 (d, 6H, J =7.2Hz)
Me2Sn(L3)2 8.48(s) — 7.10 (d, 2H, J =3.9Hz);
7.09 (d, 2H, J =3.9Hz) 2.92–2.83 (m, 2H); 1.18 (d,12H, J =7.2Hz)Bioinorganic Chemistry and Applications 5
Table 4: C13 NMR chemical shifts of the ligands and their metal complexes.
Compound C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 M–CH3
HL1(BTMMT) 124.05 135.85 139.06 143.92 166.42 153.51 157.32 15.67 — — —
Me2SiCl(L1) 131.77 132.39 137.24 137.94 183.07 138.32 156.08 9.5 — — 18.11
Me2Si(L1)2 116.70 132.06 133.60 141.23 160.96 147.79 149.04 11.32 — — 28.22
Me2SnCl(L1) 120.65 132.03 132.98 142.52 162.54 147.89 148.26 11.65 — — 30.11
Me2Sn(L1)2 116.03 131.94 132.82 141.82 161.23 147.33 147.58 11.37 — — 32.11
HL2(BTMPT) 120.15 131.09 134.59 138.97 162.23 152.73 152.92 13.69 19.29 26.91 —
Me2SiCl(L2) 119.30 131.84 135.64 139.04 183.06 154.32 156.02 13.76 19.44 26.81 18.23
Me2Si(L2)2 128.18 129.28 131.98 141.72 161.81 153.26 154.25 14.58 19.02 25.95 24.66
Me2SnCl(L2) 126.23 128.56 131.23 140.58 162.48 152.56 154.85 14.23 18.65 26.42 31.32
Me2Sn(L2)2 124.26 130.45 132.05 141.62 161.98 153.26 154.26 14.42 18.87 26.86 32.00
HL3(BTIMT) 124.18 135.96 139.22 143.95 160.79 157.86 157.26 30.27 24.44 24.44 —
Me2SiCl(L3) 118.67 132.03 135.82 139.08 161.95 154.71 154.98 25.56 19.79 19.79 19.12
Me2Si(L3)2 120.42 129.45 133.25 138.55 160.78 152.53 151.25 28.45 20.25 22.76 29.10
Me2SnCl(L3) 122.62 128.46 132.46 139.42 161.86 153.24 154.25 27.56 19.45 24.57 29.88
Me2Sn(L3)2 124.56 130.54 135.03 141.21 162.46 154.48 153.24 28.89 21.22 26.43 31.89
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Figure 3: 1H NMR spectrum of Si (1:1) metal complex of ligand
(HL3).
showing that all 1:1 and 1:2 complexes are nonelectrolytic
in nature Table 1.
3.1. Electronic Spectra. The electronic spectra of the ligands
HL1−3 and their corresponding Si(IV) and Sn(IV) metal
complexes were recorded. The electronic spectra of ligands
HL1,H L 2,a n dH L 3 exhibit maxima at 388nm, 364nm, and
387nm, respectively, which could be assigned to the n-π∗
transition of the azomethine group. These bands show a blue
shift in 1:1 and 1:2, Si(IV) and Sn(IV) metal complexes
and appear at 368nm, 369nm, 358nm, 369nm, 362nm,
364nm, 359nm, 362nm, 372nm, 368nm, 376nm and
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Figure 4: 29S iN M Rs p e c t r u mo fS i( 1:1 )m e t a lc o m p l e xo fl i g a n d
(HL1).
366nm for Me2SiCl(L1), Me2Si(L1)2,M e 2SnCl(L1), Me2Sn
(L1)2,M e 2SiCl(L2), Me2Si(L2)2,M e 2SnCl(L2), Me2Sn(L2)2,
Me2SiCl(L3), Me2Si(L3)2,M e 2SnCl(L3), and Me2Sn(L3)2,
respectively, and indicating the coordination of azomethine
nitrogen atom to the metal atom [16]. In addition to
this, the three medium intensity bands at 244nm, 240nm,
and 260nm due to π-π∗ transition in the ligands remain
unchanged or show a minor change in the spectra of metal
complexes [17].
3.2. IR Spectra. In the IR spectra of the ligands, a broad
band in the region of 3117–3094cm−1 due to ν(N–H)
[13]a n dab a n da t∼1120cm−1 due to ν(C=S) [21],
indicating the thione form, while a weak band observed
around 2750cm−1 due to ν(S–H) vibrations suggested that
the Schiﬀ bases exhibit thiol-thione tautomerism (Figure 1)
[22, 23]. The deprotonation of −SH group of triazole was
indicated by the absence of bands in the spectra of metal
complexes due to ν(S–H), ν(C=S), and ν(N–H). A new band
appears ∼740cm−1 in the spectra of the complexes, which6 Bioinorganic Chemistry and Applications
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Figure 5: Comparison of antifungal activity of compounds with commercial antibiotic.
is assigned to ν(C–S) and which indicates the complexation
of ligands through S-atom with the metal atom. The metal
sulphur bond formation is further supported by a band
at ∼452cm−1 and ∼426cm−1 for ν(Si–S) [24]a n dν(Sn–
S) [25] in the spectra of organosilicon and organotin
complexes, respectively. A sharp and strong band in the
region of 1582–1597cm−1 for ν(N=CH) [26]i nc a s eo f
ligands, was shifted to a higher wavelength number and
appears in the region of 1628–1674cm−1 in the spectra
of metal complexes, indicating the coordination of ligands
through azomethine nitrogen to the metal atom. The metal
nitrogen bond was further supported by the presence of a
band at about ∼535cm−1 for ν(Sn–N) [27]a n d∼575cm−1
for ν(Si–N) [28]. A strong band in the region of 425–
378cm−1 was assigned to ν(M–Cl) [29]. The IR-spectral data
of the ligands and their metal complexes are listed in Table 2.
3.3. 1HN M RS p e c t r a .The 1H NMR spectra of the ligands
show the –SH proton signal at δ 10.47(s), δ 13.75(s),
and δ 11.10 (s)ppm for HL1,H L 2,a n dH L 3,r e s p e c t i v e l y
[26]( Figure 2). The disappearance of the signal due to
–SH proton in the spectra of metal complexes indicates
the deprotonation of the thiol group and supports the
coordination of ligand through sulphur atom to the metal
atom. A signal at δ 11.72(s), 10.91(s), and 10.63 (s)ppm
was observed due to azomethine proton in the spectra of
free ligands HL1,H L 2 and HL3, respectively, which moves
upﬁeld in the 1H NMR spectra of metal complexes [13],
indicates the bonding through the azomethine nitrogen
atom to the central metal atom (Figure 3). The aromatic
protons of the thiophene moiety in the ligands appear as
two doublets, which remain more or less unchanged in the
1H NMR spectra of the metal complexes. Some additional
signals at δ 2.45ppm (s, CH3,T r i a z o l e ) ,δ 2.78ppm (t, CH2–
CH2–CH3,T r i a z o l e ) ,δ 1.69–1.63 ppm (m, CH2–CH2–CH3,
Triazole), δ 1.03ppm (t, CH2–CH2–CH3,T r i a z o l e ) ,δ 3.29–
3.20ppm (CH(CH3)2,T r i a z o l e ) ,δ 1.36ppm (d, CH(CH3)2,
Triazole) and also appeared in the 1HNMR spectra of the
ligands, and their metal complexes, reported in the Table 3.
The additional signals in the region δ 0.3–1.5ppm are also
observed in the spectra of complexes due to CH3–M group.
3.4. 13CN M RS p e c t r a .The 13C NMR spectral data of
ligands HL1,H L 2,a n dH L 3, and their corresponding 1:1
and 1:2 metal complexes [17, 18]h a v eb e e nr e p o r t e di n
Table 4. The signal due to the carbon atom attached to
the azomethine group in the ligands HL1,H L 2,a n dH L 3
appear at δ 166.42ppm, δ 162.23ppm, and δ 160.79ppm,
respectively. However, in the spectra of the corresponding
metal complexes, the shift in the 13C resonance indicate the
coordination of nitrogen atom of azomethine group with the
central atom in 1:1 and 1:2 metal complexes. Moreover, the
shifting of the 13C resonance of triazole which is attached to
sulphur atom in the spectra of 1:1 and 1:2 metal complexes
compared to the free ligands indicates the coordination
through sulphur atom with the central metal atom. The new
signal due to the methyl groups attached to the metal atom
in the spectra of metal complexes has also been reported in
Table 4.
3.5. 29Si and 119Sn NMR Spectra. The value of δ 29Si
and δ 119Sn indicates the coordination number of the
central metal atom in the corresponding complexes [30],
and generally (Figure 4), 29Si and 119Sn chemical shifts
move to lower frequency with increasing coordination
number of the metal atoms. The spectrum shows in
each case only a sharp singlet indicating the forma-
tion of single species. 29Si and 119Sn NMR spectra of
{Me2SiCl(L1)},{Me2Si(L1)2},{Me2SnCl(L1)},a n d{Me2Sn
(L1)2} complexes show sharp signals at δ−110.41ppm,
δ−123.35ppm, δ−176.46ppm, and δ−265.26ppm, respec-
tively, Which is indicative of pentacoordinated and hexaco-
ordinated around the silicon and tin atom [8].Bioinorganic Chemistry and Applications 7
Table 5: In vitro antibacterial activity of the ligands and their metal
complexes.
Compounds
Zone of inhibition (mm)
a
S. aureus B. subtilis E. coli P. aeruginosa
HL1(BTMMT) 16.2 15.6 — —
Me2SiCl(L1) 21.6 — — —
Me2Si(L1)2 20.3 — — —
Me2SnCl(L1) 24.6 22.6 — —
Me2Sn(L1)2 — 18.6 — —
HL2(BTMPT) 18.8 18.6 — —
Me2SiCl(L2) 23.6 21.3 — —
Me2Si(L2)2 17.3 15.2 — —
Me2SnCl(L2)— — — —
Me2Sn(L2)2 15.3 16.3 — —
HL3(BTIMT) — 15.9 — —
Me2SiCl(L3) — 20.2 — —
Me2Si(L3)2 — 16.2 — —
Me2SnCl(L3) — 16.8 — —
Me2Sn(L3)2 — 15.3 — —
Ciproﬂoxacin 27.6 26 — —
—: No activity.
aValues, including diameter of the well (8mm), are means of three
replicates.
Table 6:Minimuminhibitoryconcentration(MIC)inμg/mLofthe
ligands and their metal complexes.
Compound S. aureus B. subtilis
HL1(BTMMT) >128 128
Me2SiCl(L1)6 4 N t
Me2Si(L1)2 64 Nt
Me2SnCl(L1)2 8 5 4
Me2Sn(L1)2 Nt 64
HL2(BTMPT) Nt 128
Me2SiCl(L2)2 8 5 8
Me2Si(L2)2 128 >128
Me2SnCl(L2)— —
Me2Sn(L2)2 128 128
HL3(BTIMT) Nt 128
Me2SiCl(L3) Nt 128
Me2Si(L3)2 Nt 128
Me2SnCl(L3) Nt 128
Me2Sn(L3)2 Nt 128
Ciproﬂoxacin 5 5
Nt: Not tested.
4.BiologicalActivities
The bactericidal and fungicidal activities of the free ligands
and their metal complexes against various gram positive and
gram negative bacteria and fungi are reported in Tables 5, 6,
and 7.
Table 7: In vitro antifungal activity of the ligands and their metal
complexes.
Compound
Mycelial growth inhibition (%)
Aspergillus niger Aspergillus ﬂavus
HL1(BTMMT) 44.4 45.5
Me2SiCl(L1) 55.2 52.5
Me2Si(L1)2 68.2 64.8
Me2SnCl(L1) 48.8 52.5
Me2Sn(L1)2 44.4 50
HL2(BTMPT) 44.4 44.4
Me2SiCl(L2) 51.1 53.3
Me2Si(L2)2 44.4 48.8
Me2SnCl(L2) 49.4 48.4
Me2Sn(L2)2 44.4 48.8
HL3(BTIMT) 50 53.3
Me2SiCl(L3) 48.8 44.4
Me2Si(L3)2 58.1 59.5
Me2SnCl(L3) 45 48.8
Me2Sn(L3)2 50 51.1
Fluconazole 81.1 77.7
4.1. In Vitro Antibacterial Assay. The newly synthesized
ligands and their metal complexes were screened for their
antibacterial activities against test bacteria namely Staphy-
lococcus aureus, Bacillus subtilis (Gram positive), Escherichia
coli, and Pseudomonas aeruginosa (Gram negative). The
activity is determined by reported Agar well diﬀusion
method [31, 32]. All the microbial cultures were adjusted
to 0.5 McFarland standards, which is visually comparable to
a microbial suspension of approximately 1.5×108 cfu/mL.
20mLofMuellerHintonAgarmediumwaspouredintoeach
petri plate and plates were swabbed with 100μL inocula of
the test microorganisms and kept for 15min for adsorption.
Using sterile cork borer of 8mm diameter, wells were bored
into the seeded agar plates, and these were loaded with a
100μL volume with concentration of 4.0mg/mL of each
compound reconstituted in the DMSO. All the plates were
incubated at 37◦C for 24hrs. Antibacterial activity of each
synthetic compound was evaluated by measuring the zone of
growthinhibitionagainstthetestorganismswithzonereader
(Hi Antibiotic zone scale). DMSO was used as a negative
control, whereas Ciproﬂoxacin was used as positive control.
This procedure was performed in three replicate plates for
each organism.
4.2. Determination of Minimum Inhibitory Concentration
(MIC). MIC of the various compounds against bacterial
strains was tested through a macrodilution tube method as
recommended by NCCLS [33]. In this method, the various
test concentrations of synthesized compounds were made
from 128 to 0.25μg/mL in sterile tubes nos. 1 to 10. 100μL
sterile Mueller Hinton Broth (MHB) was poured in each
sterile tube followed by addition of 200μLt e s tc o m p o u n di n
tube 1. Twofold serial dilutions were carried out from tube8 Bioinorganic Chemistry and Applications
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1 to the tube 10 and excess broth (100μL) was discarded
from the test tube no. 10. To each tube, 100μL of standard
inoculum (1.5×108 cfu/mL) was added. Ciproﬂoxacin was
used as control. Turbidity was observed after incubating the
inoculated tubes at 37◦C for 24hrs.
4.3. In Vitro Antifungal Activity. The ligands and their metal
complexes were also screened for their antifungal activity
against two fungi, namely, A. niger and A. ﬂavus, the ear
pathogens isolated from the patients of Kurukshetra [34],
by poison food technique [35] .T h em o u l d sw e r eg r o w n
on Sabouraud dextrose agar (SDA) at 25◦Cf o r7d a y s
and used as inocula. The 15mL of molten SDA (45◦C)
was poisoned by the addition of 100μLv o l u m eo fe a c h
compound having concentration of 4.0mg/mL reconstituted
in the DMSO, poured into a sterile petri plate and allowed
it to solidify at room temperature. The solidiﬁed poisoned
agar plates were inoculated at the center with fungal plugs
(8mm diameter) obtained from the colony margins and
incubated at 25◦C for 7 days. DMSO was used as the negative
control whereasFluconazole was used as the positive control.
The experiments were performed in triplicates. Diameter
of fungal colonies was measured and expressed as percent
mycelial inhibition by applying the formula.
Percent inhibition of mycelial growth =
dc −dt
dc ×100
,( 2 )
where dc is the average diameter of fungal colony in negative
control sets and dt is the average diameter fungal colony in
experimental sets.
4.4. Observations. The antibacterial data reveals that the
complexesaresuperiorcomparedtothefreeligands.Thefree
ligands and their metal complexes are active against Gram-
positive bacteria (Staphylococcus aureus and Bacillus subtilis)
and inactive against gram negative bacteria (Escherichia coli
and Pseudomonas aeruginosa). Among the synthesized com-
pounds tested compounds, Me2SnCl(L1)a n dM e 2SiCl(L2)
show more antibacterial activity that is, near to standard
drug (Ciproﬂoxacin) (Table 5). In the series, the MIC of the
compounds ranged between 28–128μg/mL against Gram-
positive bacteria. Compound Me2SnCl(L1)a n dM e 2SiCl(L2)
show highest MIC of 28μg/mL against S. aureus (Table 6).
The antifungal activity of compounds (Figure 5) shows more
than 50% inhibition of mycelia growth against Aspergillus
niger and A. ﬂavus (Table 7). Thus, it can be postulated that
furtherstudiesofthesecomplexesinthisdirectioncouldlead
to more interesting results.
5. Conclusion
Trigonal bipyramidal and octahedral geometries have been
proposed for 1:1 and 1:2 organosilicon(IV) and organ-
otin(IV) complexes with the help of various physico-
chemical studies like IR, UV, 1H, 13C, 29Si, and 119Sn NMR
(Figure 6). The free ligands, and their metal complexes
were screened against various fungi and bacteria to access
their potential as antimicrobial agents. The antimicrobial
data reveals that the complexes are superior to the free
ligands and their toxicity has increased as per the increase inBioinorganic Chemistry and Applications 9
concentration. These compounds were found more potent
inhibitor of fungal growth as compared to the bacterial
culture.
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